Ayato Takada Selected Research

Filoviridae Infections

11/2020	A biaryl sulfonamide derivative as a novel inhibitor of filovirus infection.
11/2018	Single-Nucleotide Polymorphisms in Human NPC1 Influence Filovirus Entry Into Cells.
6/2015	Interaction between TIM-1 and NPC1 Is Important for Cellular Entry of Ebola Virus.
11/2013	Differential potential for envelope glycoprotein-mediated steric shielding of host cell surface proteins among filoviruses.
4/2013	Novel mutations in Marburg virus glycoprotein associated with viral evasion from antibody mediated immune pressure.
12/2010	C-type lectins do not act as functional receptors for filovirus entry into cells.
10/2006	Tyro3 family-mediated cell entry of Ebola and Marburg viruses.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ayato Takada Research Topics

Disease

42	Infections 05/2022 - 07/2003
14	Vesicular Stomatitis 02/2022 - 04/2002
14	Ebola Hemorrhagic Fever 01/2022 - 01/2003
13	Influenza in Birds (Avian Flu) 12/2021 - 08/2002
13	Human Influenza (Influenza) 12/2017 - 03/2004
7	Filoviridae Infections 11/2020 - 10/2006
6	Virus Diseases (Viral Diseases) 10/2018 - 07/2003
3	Disease Progression 06/2014 - 11/2003
3	Fever (Fevers) 09/2013 - 01/2003
2	Tick-Borne Diseases (Tick-Borne Disease) 05/2022 - 01/2018
2	Communicable Diseases (Infectious Diseases) 06/2005 - 01/2003
1	Zoonoses 05/2022
1	COVID-19 01/2022
1	Ascites 01/2022
1	Rabies (Hydrophobia) 06/2021
1	Inflammation (Inflammations) 01/2021
1	Granuloma 01/2021
1	Asbestosis 01/2021
1	Coinfection 06/2020
1	Reinfection 01/2019
1	Neoplasms (Cancer) 01/2019
1	Melanoma (Melanoma, Malignant) 01/2019
1	Marburg Virus Disease 11/2018
1	Severe Fever with Thrombocytopenia Syndrome 10/2018
1	Emerging Communicable Diseases (Emerging Infectious Diseases) 01/2018
1	Q Fever (Fever, Q) 01/2018
1	Deltaretrovirus Infections (BLV Infection) 04/2017
1	Genetic Predisposition to Disease (Genetic Predisposition) 01/2017
1	Type C Niemann-Pick Disease (Niemann Pick Disease, Type C) 12/2016

Drug/Important Bio-Agent (IBA)

18	AntibodiesIBA 01/2022 - 08/2002
16	VaccinesIBA 11/2020 - 01/2003
15	Glycoproteins (Glycoprotein)IBA 02/2022 - 01/2003
13	Monoclonal AntibodiesIBA 01/2022 - 01/2003
11	Antiviral Agents (Antivirals)IBA 01/2021 - 04/2002
9	Hemagglutinins (Hemagglutinin)IBA 05/2022 - 08/2002
9	Proteins (Proteins, Gene)FDA Link 01/2020 - 01/2011
7	EpitopesIBA 01/2022 - 01/2003
6	Neuraminidase (Sialidase)IBA 05/2022 - 07/2003
5	Amino Acids FDA Link 02/2022 - 01/2003
5	Complement System Proteins (Complement)IBA 01/2022 - 07/2003
5	Neutralizing AntibodiesIBA 06/2021 - 01/2003
4	AntigensIBA 01/2022 - 01/2017
4	Fc Receptors (Fc Receptor)IBA 01/2020 - 11/2003
3	Immunoglobulin G (IgG)IBA 01/2022 - 01/2014
3	avian influenza A virus hemagglutininIBA 12/2021 - 01/2017
3	Pharmaceutical PreparationsIBA 11/2020 - 10/2005
3	Viral ProteinsIBA 01/2020 - 01/2011
3	InterferonsIBA 10/2018 - 07/2006
3	Messenger RNA (mRNA)IBA 10/2018 - 04/2002
3	C-Type Lectins (C-Type Lectin)IBA 01/2014 - 05/2010
2	tert-butylserineIBA 05/2022 - 01/2018
2	Immune Sera (Antisera)IBA 01/2022 - 11/2011
2	NucleoproteinsIBA 01/2022 - 01/2012
2	Basic Amino Acids (Basic Amino Acid)IBA 12/2021 - 01/2017
2	Viral RNAIBA 01/2021 - 03/2006
2	EnzymesIBA 06/2020 - 10/2005
2	Immunoglobulin A (IgA)IBA 01/2020 - 01/2014
2	Synthetic Vaccines (Recombinant Vaccines)IBA 01/2019 - 06/2005
2	Biological ProductsIBA 01/2016 - 03/2004
2	Interferon Type IIBA 01/2016 - 10/2010
2	Oseltamivir (Tamiflu)FDA Link 01/2013 - 10/2005
2	Peptides (Polypeptides)IBA 01/2012 - 01/2011
1	Phenylalanine (L-Phenylalanine)FDA Link 02/2022
1	IgG Receptors (Fc gamma RI)IBA 01/2022
1	TrypsinIBA 12/2021
1	RNA (Ribonucleic Acid)IBA 12/2021
1	Carbon Nanotubes (Carbon Nanotube)IBA 01/2021
1	propagermanium (Ge 132)IBA 01/2021
1	PropionatesIBA 01/2021
1	InflammasomesIBA 01/2021
1	SulfonamidesIBA 11/2020
1	Small Interfering RNA (siRNA)IBA 01/2020
1	Endosomal Sorting Complexes Required for TransportIBA 01/2020
1	Neoplasm Antigens (Tumor Antigens)IBA 01/2019
1	Interferon-betaIBA 10/2018
1	Interferon Regulatory Factor-3 (Interferon Regulatory Factor 3)IBA 10/2018
1	Phosphotransferases (Kinase)IBA 10/2018
1	Heparin (Liquaemin)FDA LinkGeneric 01/2018
1	PhosphatidylserinesIBA 01/2018
1	Heparan Sulfate Proteoglycans (Heparan Sulfate Proteoglycan)IBA 01/2018
1	isocitric acid (isocitrate)IBA 01/2018
1	Ion Channels (Ion Channel)IBA 12/2017
1	Viral DNAIBA 08/2017
1	DNA-Directed RNA Polymerases (RNA Polymerase)IBA 08/2017
1	DNA (Deoxyribonucleic Acid)IBA 04/2017
1	Antiviral Restriction FactorsIBA 12/2016
1	Bone Marrow Stromal Antigen 2IBA 12/2016
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 12/2016
1	ZMappIBA 02/2016
1	Cathepsin LIBA 01/2014
1	OsteopontinIBA 01/2012
1	RestonIBA 01/2012
1	MucinsIBA 01/2012
1	Influenza Vaccines (Influenza Vaccine)FDA Link 02/2011
1	HLA-A24 AntigenIBA 01/2011
1	Polysaccharides (Glycans)IBA 12/2010
1	Immunoglobulin M (IgM)IBA 11/2010
1	Single-Chain AntibodiesIBA 10/2010

Therapy/Procedure

7	Therapeutics 11/2020 - 01/2003
1	Immunotherapy 10/2010